Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Stem cell transplantation impairs dendritic cell trafficking and herpesvirus immunity
Carol A. Wilke, Mathew M. Chadwick, Paul R. Chan, Bethany B. Moore, Xiaofeng Zhou
Carol A. Wilke, Mathew M. Chadwick, Paul R. Chan, Bethany B. Moore, Xiaofeng Zhou
View: Text | PDF
Research Article Immunology Inflammation

Stem cell transplantation impairs dendritic cell trafficking and herpesvirus immunity

  • Text
  • PDF
Abstract

Long-term survivors after hematopoietic stem cell transplantation are at high risk of infection, which accounts for one-third of all deaths related to stem cell transplantation. Little is known about the cause of inferior host defense after immune cell reconstitution. Here, we exploited a murine syngeneic BM transplantation (BMT) model of late infection with murine gammaherpesvirus 68 (MHV-68) to determine the role of conventional DC (cDC) trafficking in adaptive immunity in BMT mice. After infection, the expression of chemokine Ccl21 in the lung is reduced and the migration of cDCs into lung draining lymph nodes (dLNs) is impaired in BMT mice, limiting the opportunity for cDCs to prime Th cells in the dLNs. While cDC subsets are redundant in priming Th1 cells, Notch2 functions in cDC2s are required for priming increased Th17 responses in BMT mice, and cDC1s can lessen this activity. Importantly, Th17 cells can be primed both in the lungs and dLNs, allowing for increased Th17 responses without optimum cDC trafficking in BMT mice. Taken together, impaired cDC trafficking in BMT mice reduces protective Th1 responses and allows increased pathogenic Th17 responses. Thus, we have revealed a previously unknown mechanism for BMT procedures to cause long-term inferior immune responses to herpes viral infection.

Authors

Carol A. Wilke, Mathew M. Chadwick, Paul R. Chan, Bethany B. Moore, Xiaofeng Zhou

×

Figure 2

Impaired migration of cDCs from the lung to dLN in BMT mice determined by the kinetics of cDC subsets in the lung and dLN or tracking CFSE-labeled lung cDCs.

Options: View larger image (or click on image) Download as PowerPoint
Impaired migration of cDCs from the lung to dLN in BMT mice determined b...
(A) Gating strategy. Lung or dLN Single-cell suspensions were prepared from mice at 3 dpi. Doublet-cell excluded live lung cells were plotted as Siglec-F vs. CD64 to exclude Siglec-F+ and/or CD64+ macrophages and monocyte-derived cells. Among the remaining lung cells, cDCs were identified as a CD11chiMHCIIhi population, which can be further differentiated as cDC1s and cDC2s based on their expression of CD103 and CD11b. Similarly, migratory cDCs in dLN were identified as a CD11c+MHCIIhi population with cDC1 and cDC2 subsets. (B) Kinetics of cDC1s and cDC2s in the lungs or dLN of non-BMT or BMT mice at 0, 2, or 3 dpi (n = 8–13, lung; n = 4–6, dLN). The absolute numbers of cDC1s or cDC2s per lung or dLN were calculated by multiplying the total cell number of the organ with the percentage of the cell type determined by flow cytometry (mean ± SEM). Symbols represent individual data points. ***P < 0.001; ****P < 0.0001, Student’s t test (2 tailed) between non-BMT and BMT mice. Similar results were obtained in 2 additional experiments. (C and D) Two days after viral infection, non-BMT or BMT mice were instilled with CFSE dye via oropharyngeal aspiration. Lung dLNs were harvested at 18 hours after CFSE instillation. Single-cell suspensions were prepared for antibody staining and flow cytometric analysis. (C) Live single dLN cells were pregated for mDCs as A, and 2-parameter contour plots for CD103 and CD11b expression were analyzed for cDC1 and cDC2 subsets. Numbers indicate the percent of cells in the gate. Single-color histograms determined the percent of CFSE+ cells in each cDC subset. (D) Absolute numbers of CFSE+ cells of each cDC subset per dLN of non-BMT (n = 8) or BMT (n = 8) mice, calculated by multiplying the total cell number of a dLN with the percentage of CFSE+ cells (mean ± SEM). Symbols represent individual mouse data points. Data were pooled from 2 independent experiments. *P < 0.05; **P < 0.01, Student’s t test (2 tailed). BMT, BM transplantation; cDC1, type 1 conventional DC; dLN, draining lymph node; mDC, migratory DC.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts